Moody’s Investors Service recently raised its rating on Atlantic Health System from “A1” to “Aa3.” The rating upgrade was based on several factors, including the health system’s stable operating performance, balance sheet growth and favorable market position.
S&P recently affirmed its “AA-” rating on Atlantic Health System. The affirmation was based on a number of factors, including the health system’s strong market position. Only one other health system in New Jersey has an “AA-” rating from S&P.
Atlantic Health System’s outlook with Moody’s and S&P is stable.
“These ratings further demonstrate the value of developing our connections to the communities we serve through wise growth, investment in innovation and continuously improving care,” Kevin Lenahan, senior vice president, CFO and chief administrative officer of Atlantic Health System, said in a press release.
More articles on healthcare finance:
Quorum Health sees net loss narrow to $30.6M, plans more hospital sales
Tenet’s net loss balloons to $56M on lower patient volume
Physician advocates: ‘We can only judge CHS by its actions, not its words’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
